 |
| 04-Jun-13 | Reiterated |
Deutsche Bank |
Hold |
$98 → $106 |
|
| 08-Mar-13 | Reiterated |
Northland Capital |
Market Perform |
$105 → $111 |
|
| 01-Feb-13 | Reiterated |
Barclays |
Overweight |
$117 → $112 |
|
| 01-Feb-13 | Initiated |
Mizuho |
Neutral |
$88 → $94 |
|
| 04-Jan-13 | Reiterated |
Deutsche Bank |
Hold |
$93 → $97 |
|
| 20-Nov-12 | Initiated |
Stifel Nicolaus |
Hold |
|
|
| 24-Oct-12 | Reiterated |
Mizuho |
Neutral |
$93 → $88 |
|
| 24-Sep-12 | Upgrade |
Barclays |
Underweight → Overweight |
$101 → $117 |
|
| 25-Apr-12 | Reiterated |
Mizuho |
Neutral |
$86 → $93 |
|
| 23-Feb-12 | Initiated |
Northland Securities |
Market Perform |
$105 |
|
| 23-Sep-11 | Reiterated |
Barclays Capital |
Underweight |
$82 → $87 |
|
| 16-Sep-11 | Initiated |
Rodman & Renshaw |
Mkt Perform |
|
|
| 01-Feb-11 | Downgrade |
Morgan Joseph |
Buy → Hold |
|
|
| 18-Jan-11 | Reiterated |
Deutsche Bank |
Hold |
$93 → $97 |
|
| 10-Sep-10 | Initiated |
Caris & Company |
Average |
$88 |
|
| 08-Jul-10 | Upgrade |
Morgan Joseph |
Hold → Buy |
$97 |
|
| 24-Mar-10 | Initiated |
CL King |
Strong Buy |
|
|
| 10-Mar-10 | Initiated |
Morgan Joseph |
Hold |
|
|
| 29-Jan-10 | Upgrade |
Piper Jaffray |
Underweight → Neutral |
|
|
| 21-Dec-09 | Reiterated |
Credit Suisse |
Neutral |
$85 → $78 |
|
|
|
| 16-Jun-13 06:46AM | Gloomy Prospects For Medical Device Companies at Seeking Alpha |
| 14-Jun-13 05:00PM | C.R. Bard Inc. (BCR): Today's Featured Health Services Winner at TheStreet |
| 08:10AM | A New High for CR Bard Zacks |
| 13-Jun-13 07:16PM | Bard Increases Dividend 5% at Motley Fool |
| 05:25PM | Bard Beefs Up Shareholder Return Zacks |
| 02:13PM | C.R. Bard Reaches New 52-Week High (BCR) at TheStreet |
| 01:08PM | 4 Stocks Raising The Health Services Industry Higher at TheStreet |
| 12-Jun-13 06:25PM | CR Bard to buyback $500M in common stock AP |
| 04:43PM | After-Hours Buzz: H&R Block, Safeway, PVH & More at CNBC |
| 04:09PM | C.R. Bard authorizes $500M stock repurchase at theflyonthewall.com |
| 04:06PM | InPlay: C.R. Bard increases quarterly dividend by 5% to $0.21 per share from $0.20 per share; announces $500 mln share repurchase authorization Briefing.com |
| 04:05PM | Bard Increases Quarterly Dividend Business Wire |
| 04:05PM | Bard Announces $500 Million Share Repurchase Authorization Business Wire |
| 06-Jun-13 01:20PM | Bard Begins Lutonix BTK Trial Zacks |
| 06:30AM | [video] Barge Into Bard, Microsoft Shares at TheStreet |
| 05-Jun-13 06:30PM | CR Bard Reiterated at Neutral Zacks |
| 04-Jun-13 11:02AM | InPlay: C.R. Bard announces first patient enrolled in Lutonix Below the Knee clinical trial Briefing.com |
| 11:01AM | Bard Announces First Patient Enrolled in Lutonix Below the Knee (BTK) Clinical Trial Business Wire |
| 01-Jun-13 04:27AM | [$$] Preview at Barrons.com |
| 20-May-13 01:20PM | Interesting BCR Put And Call For January 2014 at TheStreet |
| 19-May-13 10:05PM | The Top 35 Dividend Champions With Regard To Long-Term Stock Price Appreciation at Seeking Alpha |
| 17-May-13 10:45AM | Wall Street Transcript Interview with Mark W. Oelschlager, Portfolio Manager at Oak Associates, Ltd.: A Health Sciences Fund with a Long-Term Focus Wall Street Transcript |
| 16-May-13 03:15AM | Dividend Champions: 4 Increases Expected By July 31 at Seeking Alpha |
| 14-May-13 04:21PM | Vaginal Bulge Surgery Fails in One in Four Women in Study at Bloomberg |
| 01:27PM | Bard to pay $51M to resolve kickback investigation AP |
| 11:08AM | [$$] C.R. Bard to Pay $48.3 Million to Settle Kickback Case -DOJ at The Wall Street Journal |
| 13-May-13 06:44PM | C R Bard to pay $48 mln to settle kickback allegations, DOJ says at Reuters |
| 10-May-13 09:25AM | BARD C R INC /NJ/ Files SEC form 8-K, Other Events EDGAR Online |
| 03-May-13 11:00AM | Bard to Host Investor Conference Business Wire |
| 02-May-13 11:22AM | C.R. Bard Breaks Above 200-Day Moving Average - Bullish For BCR at TheStreet |
| 09:23AM | This Medical Company Is Not Cheap at Motley Fool |
| 30-Apr-13 01:04PM | BARD C R INC /NJ/ Financials EDGAR Online Financials |
| 29-Apr-13 12:45PM | It Gets A Little Harder From Here For Covidien at Investopedia |
| 25-Apr-13 10:34AM | Why C.R. Bard Is Poised to Outperform at Motley Fool |
| 24-Apr-13 09:58AM | C.R. Bard Stock To Go Ex-dividend Tomorrow (BCR) at TheStreet |
| 08:40AM | Bard Beats on 1Q Earnings, Profit Slumps Zacks |
| 06:13AM | BARD C R INC /NJ/ Files SEC form 10-Q, Quarterly Report EDGAR Online |
| 23-Apr-13 09:10PM | CR Bard Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha |
| 05:04PM | CR Bard Earnings: Heres Why Investors are Excited Now at Wall St. Cheat Sheet |
| 05:00PM | C. R. Bard, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN |
| 04:25PM | InPlay: C.R. Bard beats by $0.02, beats on revs Briefing.com |
| 04:05PM | Bard Announces First Quarter Results Business Wire |
| 10:30AM | C.R. Bard About To Put More Money In Your Pocket at Forbes |
| 09:16AM | BARD C R INC /NJ/ Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit EDGAR Online |
| 07:34AM | C. R. Bard, Inc. Earnings Call scheduled for 5:00 pm ET today CCBN |
| 07:07AM | Q1 2013 C. R. Bard, Inc. Earnings Release - After Market Close CCBN |
| 22-Apr-13 02:00PM | Will CR Bard Miss Earnings this Quarter? Zacks |
| 19-Apr-13 10:02AM | Buy This Healthcare Outperformer at Motley Fool |
| 08:52AM | BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of S EDGAR Online |
| 18-Apr-13 12:32PM | Daily Dividend Report: KMI, MS, ETR, BCR, LLTC at Forbes |
| 09:34AM | CR Bard Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 17-Apr-13 04:05PM | Bard Declares Quarterly Dividend Business Wire |
| 10:46AM | CR Bard Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 07:31AM | Coloplast Falls Amid Vaginal Mesh Lawsuits: Copenhagen Mover at Bloomberg |
| 07:09AM | A Look At The Prostrate Cancer Treatment Market at Seeking Alpha |
| 16-Apr-13 01:33PM | J&J tops estimates as prescription, OTC drugs shine Reuters |
| 15-Apr-13 09:06AM | CR Bard Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 10-Apr-13 12:55PM | AngioDynamics Still Struggling To Get Back On Track at Investopedia |
| 08-Apr-13 10:30AM | Bard to Host Earnings Conference Call on April 23, 2013 Business Wire |
| 10:17AM | J&J slips after JPMorgan analyst downgrades stock theflyonthewall.com |
| 09:21AM | CR Bard Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 01:00AM | A Hidden Reason That CR Bard's Earnings Are Outstanding at Motley Fool |
| 05-Apr-13 08:57AM | Logitech Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 01-Apr-13 10:22AM | BARD C R INC /NJ/ Files SEC form 8-K, Other Events EDGAR Online |
| 09:55AM | BARD C R INC /NJ/ Files SEC form 8-K, Material Impairments EDGAR Online |
| 28-Mar-13 08:13PM | Several Big Growth Stories In Biotech: Keith Markey at Seeking Alpha |
| 27-Mar-13 02:47AM | BARD C R INC /NJ/ Files SEC form 8-K, Other Events EDGAR Online |
| 22-Mar-13 09:06AM | Liberty Global EVP Sells 20K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 21-Mar-13 09:36AM | CR Bard Director Sells More Than 61K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 18-Mar-13 09:27AM | Cavium Networks Senior VP Sells 20K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 09:00AM | C.R. Bard Director Sells 100K Shares and 4 Insider Sales to Note at Wall St. Cheat Sheet |
| 15-Mar-13 12:00PM | Ortho and Cardio: Larger Caps Show Up to Double-Digit Upside in 2013, Outperforming Some of the Smaller Medical Device Companies Wall Street Transcript |
| 11:02AM | Wall Street Transcript Interview with Shai N. Gozani, President, CEO and Director of NeuroMetrix, Inc. (NURO) Wall Street Transcript |
| 14-Mar-13 01:38PM | CR Bard Reiterated at Neutral Zacks |
| 13-Mar-13 01:10PM | CR Bard Inc. Presents at Barclays Global Healthcare Conference, Mar-13-2013 11:15 AM at Seeking Alpha |
| 06-Mar-13 10:30AM | Bard to Present at Barclays Global Healthcare Conference Business Wire |
| 04-Mar-13 01:06AM | A Hidden Reason CR Bard's Future Looks Bright at Motley Fool |
| 28-Feb-13 12:22PM | J&J Owes $7.76 Million in Punitives in Vaginal Mesh Case at Bloomberg |
| 27-Feb-13 05:50PM | CR Bard Inc. Presents at Citi 2013 Global Healthcare Conference, Feb-27-2013 02:15 PM at Seeking Alpha |
| 26-Feb-13 05:13PM | J&J Seeks to Avoid Punitives After Losing Mesh Verdict at Bloomberg |
| 01:16PM | J&J Seeks to Avoid Punitives After Losing Mesh Verdict at Bloomberg |
| 01:06PM | BARD C R INC /NJ/ Financials EDGAR Online Financials |
| 12:42AM | J&J Told to Pay $3.35 Million in First Vaginal Mesh Case at Bloomberg |
| 25-Feb-13 05:02PM | J&J Told to Pay $3.35 Million in First Vaginal Mesh Case at Bloomberg |
| 05:02PM | J&J Failed to Warn of Vaginal Mesh Risks, Jury Says at Bloomberg |
| 12:44PM | J&J Failed to Warn of Vaginal Mesh Risks, Jury Says at Bloomberg |
| 11:28AM | J&J Failed to Warn of Vaginal Mesh Risks, N.J. Jury Rules at Bloomberg |
| 10:30AM | Bard to Present at Raymond James Institutional Investor Conference Business Wire |
| 23-Feb-13 10:18AM | A Value Play in Healthcare at Motley Fool |
| 22-Feb-13 05:03PM | J&J Jury Reaches No Verdict After Fourth Day in Mesh Case at Bloomberg |
| 12:28PM | Analyst Moves: BCR, NTSP at Forbes |
| 08:35AM | J&J Discloses Government Investigations of Hips, Mesh at Bloomberg |
| 21-Feb-13 01:40PM | J&J Jury Rehears Testimony of Woman Suing Over Vaginal Mesh at Bloomberg |
| 20-Feb-13 03:11PM | BARD C R INC /NJ/ Files SEC form 10-K, Annual Report EDGAR Online |
| 19-Feb-13 06:14PM | J&J Jury Begins Deliberating in First Vaginal Mesh Trial at Bloomberg |
| 01:00PM | J&J Jury Begins Deliberating in First Vaginal Mesh Trial at Bloomberg |
| 15-Feb-13 04:17PM | J&J Tested Vaginal Mesh and Warned of Risks, Lawyer Says at Bloomberg |
| 12:59PM | J&J Warned of Vaginal Mesh Risks, Tested Properly, Lawyer Says at Bloomberg |
| 11:40AM | BARD C R INC /NJ/ Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online |
| 14-Feb-13 04:21PM | Bard to Present at Citi 2013 Global Healthcare Conference Business Wire |
|
|
| C. R. Bard, Inc. designs, manufactures, packages, distributes, and sells medical, surgical, diagnostic, and patient care devices worldwide. The company offers vascular products, such as percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, fabrics, meshes, introducers, and accessories; peripheral vascular stents, covered stents, and vascular grafts; vena cava filters; biopsy devices; electrophysiology products; and drug coated balloon devices to treat peripheral vascular disease and heart arrhythmias. Its urology products comprise Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for stone removal; catheter stabilization devices; and products for therapeutic hypothermia. The company also provides oncology products, such as specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty products include soft tissue repair products, such as hernia repair grafts and hernia fixation devices; surgical sealants for intraoperative sealing of air leaks in thoracic surgery; and other products, such as irrigation, wound drainage, and original equipment manufacturers' products. The company sells its products to hospitals, individual healthcare professionals, extended care facilities, and alternate site facilities directly, as well as through hospital/surgical supply and other medical specialty distributors. C. R. Bard, Inc. was founded in 1907 and is headquartered in Murray Hill, New Jersey. |
|
| Insider Trading |
Relationship |
Date |
Transaction |
Cost |
#Shares |
Value ($) |
#Shares Total |
SEC Form 4 |
| RING TIMOTHY M | Chairman and CEO | May 21 | Option Exercise | 54.97 | 8,312 | 456,869 | 234,035 | May 23 12:14 PM | | RING TIMOTHY M | Chairman and CEO | May 21 | Sale | 106.65 | 8,312 | 886,493 | 225,723 | May 23 12:14 PM | | BRESLAWSKY MARC C | Director | May 20 | Option Exercise | 37.54 | 2,400 | 90,087 | 14,947 | May 22 11:09 AM | | BRESLAWSKY MARC C | Director | May 20 | Sale | 107.20 | 2,400 | 257,288 | 12,547 | May 22 11:09 AM | | Morfit G Mason | Director | Apr 17 | Sale | 101.14 | 10,973 | 1,109,809 | 2,861,380 | Apr 19 04:38 PM | | Morfit G Mason | Director | Apr 16 | Sale | 101.68 | 100,000 | 10,168,000 | 2,872,353 | Apr 16 05:49 PM | | Morfit G Mason | Director | Apr 15 | Sale | 102.51 | 100,000 | 10,251,000 | 2,972,353 | Apr 16 05:49 PM | | Morfit G Mason | Director | Apr 12 | Sale | 103.01 | 100,000 | 10,301,000 | 3,072,353 | Apr 16 05:49 PM | | Morfit G Mason | Director | Apr 11 | Sale | 103.02 | 100,000 | 10,302,000 | 3,172,353 | Apr 11 05:00 PM | | Morfit G Mason | Director | Apr 10 | Sale | 102.87 | 100,000 | 10,287,000 | 3,272,353 | Apr 11 05:00 PM | | RING TIMOTHY M | Chairman and CEO | Apr 09 | Option Exercise | 54.97 | 8,312 | 456,869 | 234,035 | Apr 11 03:14 PM | | Morfit G Mason | Director | Apr 09 | Sale | 101.53 | 100,000 | 10,153,000 | 3,372,353 | Apr 11 05:00 PM | | RING TIMOTHY M | Chairman and CEO | Apr 09 | Sale | 102.00 | 8,312 | 847,824 | 225,723 | Apr 11 03:14 PM | | Morfit G Mason | Director | Apr 04 | Sale | 101.13 | 100,000 | 10,113,000 | 3,472,353 | Apr 04 05:17 PM | | Morfit G Mason | Director | Apr 03 | Sale | 101.05 | 32,749 | 3,309,286 | 3,572,353 | Apr 04 05:17 PM | | Morfit G Mason | Director | Apr 02 | Sale | 101.03 | 11,206 | 1,132,142 | 3,605,102 | Apr 04 05:17 PM | | RING TIMOTHY M | Chairman and CEO | Mar 28 | Sale | 99.88 | 10,162 | 1,014,964 | 225,723 | Apr 01 04:59 PM | | Morfit G Mason | Director | Mar 20 | Sale | 101.12 | 14,782 | 1,494,756 | 3,626,156 | Mar 20 05:14 PM | | Morfit G Mason | Director | Mar 19 | Sale | 101.33 | 61,290 | 6,210,516 | 3,640,938 | Mar 20 05:14 PM | | Morfit G Mason | Director | Mar 18 | Sale | 101.32 | 100,000 | 10,132,000 | 3,702,228 | Mar 20 05:14 PM | | Morfit G Mason | Director | Mar 15 | Sale | 101.64 | 100,000 | 10,164,000 | 3,802,228 | Mar 15 04:58 PM | | Morfit G Mason | Director | Mar 14 | Sale | 101.51 | 100,000 | 10,151,000 | 3,902,228 | Mar 15 04:58 PM | | Morfit G Mason | Director | Mar 13 | Sale | 101.14 | 100,000 | 10,114,000 | 4,002,228 | Mar 15 04:58 PM | | Morfit G Mason | Director | Mar 12 | Sale | 101.11 | 100,000 | 10,111,000 | 4,102,228 | Mar 12 06:56 PM | | Morfit G Mason | Director | Mar 11 | Sale | 101.01 | 695 | 70,202 | 4,202,228 | Mar 12 06:56 PM | | Morfit G Mason | Director | Mar 08 | Sale | 101.17 | 77,671 | 7,857,975 | 4,202,923 | Mar 12 06:56 PM | | WEILAND JOHN H | President and COO | Mar 07 | Sale | 99.52 | 10,800 | 1,074,827 | 155,345 | Mar 11 05:13 PM | | KELLY BRONWEN K | VP - Human Resources | Feb 28 | Sale | 98.90 | 2,019 | 199,675 | 23,498 | Mar 04 03:38 PM | | Lupisella Frank Jr | Vice President and Controller | Feb 27 | Sale | 99.20 | 1,811 | 179,655 | 20,398 | Mar 01 03:12 PM | | Collins Timothy P | Group Vice President | Feb 21 | Sale | 98.66 | 4,272 | 421,461 | 52,743 | Feb 22 05:50 PM | | Beasley Jim C | Group Vice President | Feb 20 | Sale | 99.87 | 4,753 | 474,688 | 43,122 | Feb 22 05:50 PM | | DeFord John A | Sr. VP Sci Tech and Clin Afrs | Feb 19 | Sale | 100.21 | 4,206 | 421,465 | 35,469 | Feb 21 02:23 PM | | Thompson Tommy G | Director | Feb 19 | Sale | 100.25 | 200 | 20,050 | 7,747 | Feb 21 02:23 PM | | WHITE TONY L | Director | Feb 05 | Option Exercise | 37.54 | 2,400 | 90,087 | 13,725 | Feb 07 05:18 PM | | WHITE TONY L | Director | Feb 05 | Sale | 99.46 | 2,400 | 238,705 | 11,325 | Feb 07 05:18 PM | | DOLCH GARY D | Sr. VP-Quality and Reg Affairs | Jan 02 | Sale | 101.00 | 3,314 | 334,714 | 27,073 | Jan 04 05:04 PM | | Beasley Jim C | Group Vice President | Dec 20 | Option Exercise | 84.44 | 33,327 | 2,814,192 | 84,075 | Dec 21 02:22 PM | | Beasley Jim C | Group Vice President | Dec 20 | Sale | 97.95 | 33,327 | 3,264,420 | 50,748 | Dec 21 02:22 PM | | Naughton Gail K | Director | Nov 14 | Sale | 95.30 | 400 | 38,120 | 2,771 | Nov 16 04:05 PM | | Alterio Sharon M | Group Vice President | Nov 07 | Sale | 96.32 | 3,025 | 291,381 | 46,159 | Nov 09 05:17 PM | | Naughton Gail K | Director | Nov 01 | Sale | 97.23 | 487 | 47,352 | 3,163 | Nov 05 01:42 PM | | Morfit G Mason | Director | Oct 03 | Sale | 105.25 | 81,543 | 8,582,401 | 4,280,594 | Oct 03 04:52 PM | | Morfit G Mason | Director | Oct 02 | Sale | 105.06 | 100,000 | 10,506,000 | 4,362,137 | Oct 03 04:52 PM | | Morfit G Mason | Director | Oct 01 | Sale | 105.08 | 100,000 | 10,508,000 | 4,462,137 | Oct 01 05:01 PM | | Morfit G Mason | Director | Sep 27 | Sale | 105.00 | 10,161 | 1,066,905 | 4,562,137 | Oct 01 05:01 PM | | Morfit G Mason | Director | Sep 26 | Sale | 105.02 | 15,929 | 1,672,864 | 4,572,298 | Sep 26 04:47 PM | | Morfit G Mason | Director | Sep 25 | Sale | 105.37 | 92,367 | 9,732,711 | 4,588,227 | Sep 26 04:47 PM | | Morfit G Mason | Director | Sep 24 | Sale | 105.34 | 100,000 | 10,534,000 | 4,680,594 | Sep 26 04:47 PM | | KELLY BRIAN P | Group Vice President | Aug 21 | Sale | 98.31 | 5,032 | 494,691 | 39,663 | Aug 23 04:34 PM | | KELLY BRONWEN K | VP - Human Resources | Aug 17 | Option Exercise | 60.36 | 24,100 | 1,454,787 | 50,676 | Aug 21 04:25 PM | | Beasley Jim C | Group Vice President | Aug 17 | Sale | 98.23 | 1,216 | 119,454 | 45,878 | Aug 21 04:25 PM | | KELLY BRONWEN K | VP - Human Resources | Aug 17 | Sale | 98.19 | 28,500 | 2,798,355 | 22,176 | Aug 21 04:25 PM | | Lupisella Frank Jr | Vice President and Controller | Aug 16 | Option Exercise | 81.70 | 3,806 | 310,931 | 24,501 | Aug 20 05:51 PM | | DeFord John A | Sr. VP Sci Tech and Clin Afrs | Aug 16 | Sale | 98.32 | 2,043 | 200,870 | 37,576 | Aug 20 05:51 PM | | RING TIMOTHY M | Chairman and CEO | Aug 16 | Sale | 98.57 | 21,923 | 2,160,902 | 233,653 | Aug 20 05:51 PM | | Collins Timothy P | Group Vice President | Aug 16 | Sale | 98.32 | 1,392 | 136,862 | 53,142 | Aug 20 05:51 PM | | Lupisella Frank Jr | Vice President and Controller | Aug 16 | Sale | 98.48 | 4,815 | 474,201 | 19,686 | Aug 20 05:51 PM | | WEILAND JOHN H | President and COO | Aug 15 | Sale | 98.42 | 15,554 | 1,530,896 | 161,093 | Aug 17 03:31 PM | | Morfit G Mason | Director | Aug 01 | Sale | 95.50 | 750,605 | 71,684,290 | 4,780,594 | Aug 03 04:35 PM | | Beasley Jim C | Group Vice President | Jul 30 | Option Exercise | 82.69 | 40,802 | 3,373,758 | 88,780 | Aug 01 06:12 PM | | Collins Timothy P | Group Vice President | Jul 30 | Option Exercise | 66.80 | 10,080 | 673,294 | 65,322 | Aug 01 06:12 PM | | Collins Timothy P | Group Vice President | Jul 30 | Sale | 98.01 | 10,080 | 987,901 | 55,242 | Aug 01 06:12 PM | | Beasley Jim C | Group Vice President | Jul 30 | Sale | 98.12 | 40,802 | 4,003,321 | 47,978 | Aug 01 06:12 PM |
|
|
|
|
|
|
